Spore.Bio Secures $23M Series A for Groundbreaking Microbiology Innovation

Spore.Bio, an innovative microbiology company, has secured $23 million in Series A funding, led by Localglobe. This funding is set to advance Spore.Bio’s groundbreaking microbiology testing technology, which utilizes light-power to deliver accurate insights within minutes, significantly faster than traditional methods. This technology holds promise for improving safety across various industries by potentially saving lives through rapid microbiological assessments. The company’s achievements include a partnership with the renowned Pasteur Institute and the acquisition of a local competitor, and it already has over 200 factories prepared to implement its technology. Spore.Bio aims to make a lasting impact on global food safety and public health. Alongside founders Amine Raji, Maxime Mistretta, and Mohamed Tazi, the company welcomes the involvement of the Singular team led by Raffi and Maud as it continues its mission to transform the microbiology landscape. This development marks a significant contribution to the European and global microbiology communities.